| Michael Andrew Fischer, MD | |
|
33 Bartlett St Ste 305, Lowell, MA 01852-1318 | |
| (978) 452-2200 | |
| Not Available |
| Full Name | Michael Andrew Fischer |
|---|---|
| Gender | Male |
| Speciality | Pediatrics |
| Location | 33 Bartlett St Ste 305, Lowell, Massachusetts |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1639289713 | NPI | - | NPPES |
| 1018946 | Medicaid | VT | |
| 32000361 | Medicaid | NH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 15376 (New Hampshire) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Michael Andrew Fischer, MD 33 Bartlett St Ste 305, Lowell, MA 01852-1318 Ph: (978) 452-2200 | Michael Andrew Fischer, MD 33 Bartlett St Ste 305, Lowell, MA 01852-1318 Ph: (978) 452-2200 |
News Archive
A Texas A&M researcher is discovering the demographic characteristics that can produce or lessen stress for racial and ethnic minority students in school settings.
Women with the BRCA1 or BRCA2 gene mutations, which are linked to a very high risk of breast and ovarian cancer, can safely take hormone-replacement therapy (HRT) to mitigate menopausal symptoms after surgical removal of their ovaries, according to new research from the Perelman School of Medicine at the University of Pennsylvania which will be presented Monday, June 6 during the American Society for Clinical Oncology's annual meeting.
Emergent BioSolutions Inc. today announced that it has been awarded five separate grants under the Qualifying Therapeutic Discovery Project (QTDP) Program to support continued development of its therapeutic programs in oncology and autoimmunity. The grants, with a total value of over $1.2 million, will fund Emergent's TRU-016 Small Modular ImmunoPharmaceutical (SMIP™), DRACO anti-CD3 SMIP, X1 TNF-based SCORPION™, X2 CTLA4-based SCORPION, and T-Scorps-based SCORPION therapeutic programs.
Even people who show a clear treatment response with antidepressant medications continue to experience symptoms like insomnia, sadness and decreased concentration, researchers at UT Southwestern Medical Center have found after analyzing data from the largest study on the treatment of depression.
Mayo Clinic researchers found that improvement of mood over the course of post-acute brain rehabilitation is associated with increased participation in day-to-day activities, independent living, and ability to work after rehabilitation is complete.
› Verified 2 days ago
Daniel W Dubner, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 33 Bartlett St, Lowell, MA 01852 Phone: 978-452-2200 | |
Dr. Suparna Sharma, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 295 Varnum Ave, Lowell, MA 01854 Phone: 978-937-6000 | |
Wesley Dean, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 161 Jackson St, Lowell, MA 01852 Phone: 978-937-9700 | |
Mr. Stephen A Conway, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 33 Bartlett St, Suite 305, Lowell, MA 01852 Phone: 978-452-2200 Fax: 978-441-2651 | |
Cathleen Bonacci, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 597 Merrimack St, Lowell Community Health Center, Lowell, MA 01854 Phone: 978-937-9700 Fax: 978-446-9830 | |
Purnima Baranwal, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 597 Merrimack St, Lowell, MA 01854 Phone: 978-937-9700 | |
Dr. Kristen A Klemmer, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 295 Varnum Ave, Lowell, MA 01854 Phone: 978-937-6000 |